Hemostemix Market Cap

Hemostemix has a market cap or net worth of CAD 12.86 million as of April 29, 2026. Its market cap has decreased by -1.55% in one year.

Market Cap

12.86M

Enterprise Value

15.00M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.07

Market Cap Chart

Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 12.86M, a decrease of -73.70%. That is a compound annual growth rate of -11.03%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	12.86M	-26.84%
Dec 31, 2025	17.57M	3.39%
Dec 31, 2024	17.00M	178.71%
Dec 29, 2023	6.10M	-55.27%
Dec 30, 2022	13.63M	44.06%
Dec 31, 2021	9.46M	-70.84%
Dec 31, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Rapid Dose Therapeutics	13.64M
Britannia Life Sciences	14.60M
PreveCeutical Medical	14.95M
Pharmala Biotech Holdings	15.79M
Innovotech	10.34M
Marvel Biosciences	10.08M
PharmaTher Holdings	9.10M
Glow Lifetech	8.65M

Market Cap Rankings